Primary Cells Market Segmentation
Primary Cells Source Outlook (USD Billion, 2018-2030)
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Primary Cells Type Outlook (USD Billion, 2018-2030)
Human Primary Cells
Animal Primary Cells
Primary Cells End User Outlook (USD Billion, 2018-2030)
Pharmaceutical and Biotechnology Companies
Research Institutes
Primary Cells Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
North America Primary Cells by Type
Human Primary Cells
Animal Primary Cells
North America Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
US Outlook (USD Billion, 2018-2030)
US Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
US Primary Cells by Type
Human Primary Cells
Animal Primary Cells
US Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
CANADA Outlook (USD Billion, 2018-2030)
CANADA Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
CANADA Primary Cells by Type
Human Primary Cells
Animal Primary Cells
CANADA Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Europe Outlook (USD Billion, 2018-2030)
Europe Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Europe Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Europe Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Germany Outlook (USD Billion, 2018-2030)
Germany Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Germany Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Germany Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
France Outlook (USD Billion, 2018-2030)
France Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
France Primary Cells by Type
Human Primary Cells
Animal Primary Cells
France Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
UK Outlook (USD Billion, 2018-2030)
UK Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
UK Primary Cells by Type
Human Primary Cells
Animal Primary Cells
UK Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
ITALY Outlook (USD Billion, 2018-2030)
ITALY Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
ITALY Primary Cells by Type
Human Primary Cells
Animal Primary Cells
ITALY Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
SPAIN Outlook (USD Billion, 2018-2030)
Spain Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Spain Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Spain Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
REST OF EUROPE Primary Cells by Type
Human Primary Cells
Animal Primary Cells
REST OF EUROPE Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Primary Cells by Source
Human Primary Cells
Animal Primary Cells
Asia-Pacific Primary Cells by Type
Flat-Rolled
Castings
Extrusions
Forgings
Pigments & Powder
Rod & Bar
Asia-Pacific Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
China Outlook (USD Billion, 2018-2030)
China Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
China Primary Cells by Type
Human Primary Cells
Animal Primary Cells
China Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Japan Outlook (USD Billion, 2018-2030)
Japan Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Japan Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Japan Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
India Outlook (USD Billion, 2018-2030)
India Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
India Primary Cells by Type
Human Primary Cells
Animal Primary Cells
India Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Australia Outlook (USD Billion, 2018-2030)
Australia Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Australia Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Australia Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Rest of Asia-Pacific Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Rest of Asia-Pacific Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Rest of the World Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Rest of the World Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Middle East Outlook (USD Billion, 2018-2030)
Middle East Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Middle East Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Middle East Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Africa Outlook (USD Billion, 2018-2030)
Africa Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Africa Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Africa Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
Latin America Outlook (USD Billion, 2018-2030)
Latin America Primary Cells by Source
Hematopoietic Cells
Skin Cells
Gastrointestinal Cells
Liver Cells
Lung Cells
Skeletal and Muscle Cells
Latin America Primary Cells by Type
Human Primary Cells
Animal Primary Cells
Latin America Primary Cells by End User
Pharmaceutical and Biotechnology Companies
Research Institutes
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 13
1.1.1 MARKET SYPNOSIS 14
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 15
2.2 RESEARCH OBJECTIVE 15
2.3 LIST OF ASSUMPTIONS 16
3 RESEARCH METHODOLOGY
.1.1 OVERVIEW 17
3.2 DATA MINING 17
3.3 SECONDARY RESEARCH 18
3.4 PRIMARY RESEARCH 19
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 23
3.8 VALIDATION 23
4 MARKET DYNAMICS
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 GROWING CANCER RESEARCH 25
4.2.2 WIDE RANGE OF APPLICATION OF PRIMARY CELLS FOR DISEASE TREATMENT 25
4.2.3 ADVANTAGES OF PRIMARY HUMAN CELLS OVER CELL LINES 25
4.2.4 GROWING RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES 25
4.3 RESTRAINTS 27
4.3.1 RISK OF CONTAMINATION 27
4.3.2 HIGH COST OF ADVANCED PRIMARY CELLS 27
4.4 OPPORTUNITIES 28
4.4.1 INCREASING DEMAND FOR PRIMARY CELL IN RESEARCH, INNOVATION, AND LAUNCH OF NEW DRUGS 28
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29
5.1.1 THREAT OF NEW ENTRANTS 29
5.1.2 BARGAINING POWER OF SUPPLIERS 30
5.1.3 THREAT OF SUBSTITUTES 30
5.1.4 BARGAINING POWER OF BUYERS 30
5.1.5 INTENSITY OF RIVALRY 30
5.2 VALUE CHAIN ANALYSIS 31
5.2.1 R&D AND MANUFACTURING 32
5.2.2 DISTRIBUTION 32
5.2.3 MARKETING & SALES 32
6 PRIMARY CELLS MARKET, BY SOURCE
6.1 OVERVIEW 33
6.2 HEMATOPOIETIC CELLS 35
6.3 SKIN CELLS 36
6.4 GASTROINTESTINAL CELLS 36
6.5 LIVER CELLS 36
6.6 LUNG CELLS 37
6.7 SKELETAL AND MUSCLE CELLS 37
7 PRIMARY CELLS MARKET, BY TYPE
7.1 OVERVIEW 38
7.2 HUMAN PRIMARY CELLS 39
7.3 ANIMAL PRIMARY CELLS 40
8 PRIMARY CELLS MARKET, BY END USER
8.1 OVERVIEW 41
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 43
8.3 RESEARCH INSTITUTES 43
9 GLOBAL PRIMARY CELLS MARKET, BY REGION
9.1 OVERVIEW 44
9.2 AMERICAS 46
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.2.1 NORTH AMERICA 48
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.2.1.1 US 49
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.2.1.2 CANADA 50
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.2.2 LATIN AMERICA 51
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3 EUROPE 53
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1 WESTERN EUROPE 55
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.1 GERMANY 57
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.2 UK 58
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.3 FRANCE 59
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.4 ITALY 60
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.5 SPAIN 61
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.1.6 REST OF WESTERN EUROPE 62
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.3.2 EASTERN EUROPE 63
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4 ASIA-PACIFIC 64
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.1 JAPAN 66
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.2 CHINA 67
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.3 INDIA 68
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.4 AUSTRALIA 69
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.5 SOUTH KOREA 70
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.4.6 REST OF ASIA PACIFIC 71
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.5 MIDDLE EAST & AFRICA 72
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.5.1 MIDDLE EAST 74
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
9.5.2 AFRICA 75
PRIMARY CELLS MARKET, BY SOURCE
PRIMARY CELLS MARKET, BY TYPE
PRIMARY CELLS MARKET, BY END USER
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 76
10.2 COMPETITIVE ANALYSIS 76
11 COMPANY PROFILES
11.1 ALLCELLS 77
11.1.1 COMPANY OVERVIEW 77
11.1.2 FINANCIAL OVERVIEW 77
11.1.3 PRODUCTS/SERVICES OFFERED 77
11.1.4 KEY DEVELOPMENTS 77
11.1.5 SWOT ANALYSIS 78
11.1.6 KEY STRATEGIES 78
11.2 AMERICAN TYPE CULTURE COLLECTION (ATCC) 79
11.2.1 COMPANY OVERVIEW 79
11.2.2 FINANCIAL OVERVIEW 79
11.2.3 PRODUCTS/SERVICES OFFERED 79
11.2.4 KEY DEVELOPMENTS 79
11.2.5 SWOT ANALYSIS 80
11.2.6 KEY STRATEGIES 80
11.3 AXOL BIOSCIENCE LTD 81
11.3.1 COMPANY OVERVIEW 81
11.3.2 FINANCIAL OVERVIEW 81
11.3.3 PRODUCTS/SERVICES OFFERED 81
11.3.4 KEY DEVELOPMENTS 81
11.3.5 SWOT ANALYSIS 82
11.3.6 KEY STRATEGIES 82
11.4 CELL BIOLOGICS, INC. 83
11.4.1 COMPANY OVERVIEW 83
11.4.2 FINANCIAL OVERVIEW 83
11.4.3 PRODUCTS/SERVICES OFFERED 83
11.4.4 KEY DEVELOPMENTS 83
11.4.5 SWOT ANALYSIS 84
11.4.6 KEY STRATEGIES 84
11.5 LONZA 85
11.5.1 COMPANY OVERVIEW 85
11.5.2 FINANCIAL OVERVIEW 85
11.5.3 PRODUCTS/SERVICES OFFERED 86
11.5.4 KEY DEVELOPMENTS 86
11.5.5 SWOT ANALYSIS 87
11.5.6 KEY STRATEGIES 87
11.6 MERCK KGAA 88
11.6.1 COMPANY OVERVIEW 88
11.6.2 FINANCIAL OVERVIEW 88
11.6.3 PRODUCTS/SERVICES OFFERED 89
11.6.4 KEY DEVELOPMENTS 89
11.6.5 SWOT ANALYSIS 90
11.6.6 KEY STRATEGIES 90
11.7 PROMOCELL 91
11.7.1 COMPANY OVERVIEW 91
11.7.2 FINANCIAL OVERVIEW 91
11.7.3 PRODUCTS/SERVICES OFFERED 91
11.7.4 KEY DEVELOPMENTS 91
11.7.5 SWOT ANALYSIS 92
11.7.6 KEY STRATEGIES 92
11.8 STEMCELL TECHNOLOGIES INC. 93
11.8.1 COMPANY OVERVIEW 93
11.8.2 FINANCIAL OVERVIEW 93
11.8.3 PRODUCTS/SERVICES OFFERED 93
11.8.4 KEY DEVELOPMENTS 93
11.8.5 SWOT ANALYSIS 94
11.8.6 KEY STRATEGIES 94
11.9 ZENBIO, INC. 95
11.9.1 COMPANY OVERVIEW 95
11.9.2 FINANCIAL OVERVIEW 95
11.9.3 PRODUCTS/SERVICES OFFERED 95
11.9.4 KEY DEVELOPMENTS 95
11.9.5 SWOT ANALYSIS 96
11.9.6 KEY STRATEGIES 96
11.10 THERMO FISHER SCIENTIFIC INC. 97
11.10.1 COMPANY OVERVIEW 97
11.10.2 FINANCIAL OVERVIEW 97
11.10.3 PRODUCTS/SERVICES OFFERED 98
11.10.4 KEY DEVELOPMENTS 98
11.10.5 SWOT ANALYSIS 99
11.10.6 KEY STRATEGIES 99
12 APPENDIX
12.1 REFERENCES 100
12.2 RELATED REPORTS 101
13 LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 16
TABLE 2 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 35
TABLE 3 GLOBAL PRIMARY CELLS MARKET FOR HEMATOPOIETIC CELLS, BY REGION, 2023-2030 (USD MILLION) 35
TABLE 4 GLOBAL PRIMARY CELLS MARKET FOR SKIN CELLS, BY REGION, 2023-2030 (USD MILLION) 36
TABLE 5 GLOBAL PRIMARY CELLS MARKET FOR GASTROINTESTINAL CELLS, BY REGION, 2023-2030 (USD MILLION) 36
TABLE 6 GLOBAL PRIMARY CELLS MARKET FOR LIVER CELLS, BY REGION, 2023-2030 (USD MILLION) 36
TABLE 7 GLOBAL PRIMARY CELLS MARKET FOR LUNG CELLS, BY REGION, 2023-2030 (USD MILLION) 37
TABLE 8 GLOBAL PRIMARY CELLS MARKET FOR SKELETAL AND MUSCLE CELLS, BY REGION, 2023-2030 (USD MILLION) 37
TABLE 9 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 39
TABLE 10 GLOBAL PRIMARY CELLS MARKET FOR HUMAN PRIMARY CELLS, BY REGION, 2023-2030 (USD MILLION) 39
TABLE 11 GLOBAL PRIMARY CELLS MARKET FOR ANIMAL PRIMARY CELLS, BY REGION, 2023-2030 (USD MILLION) 40
TABLE 12 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 42
TABLE 13 GLOBAL PRIMARY CELLS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION,
2023-2030 (USD MILLION) 43
TABLE 14 GLOBAL PRIMARY CELLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 43
TABLE 15 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 45
TABLE 16 AMERICAS: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 46
TABLE 17 AMERICAS: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 47
TABLE 18 AMERICAS: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 47
TABLE 19 AMERICAS: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 47
TABLE 20 NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 48
TABLE 21 NORTH AMERICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 48
TABLE 22 NORTH AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 49
TABLE 23 NORTH AMERICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 49
TABLE 24 US: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 49
TABLE 25 US: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 50
TABLE 26 US: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 50
TABLE 27 CANADA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 50
TABLE 28 CANADA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 51
TABLE 29 CANADA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 51
TABLE 30 LATIN AMERICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 51
TABLE 31 LATIN AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 52
TABLE 32 LATIN AMERICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 52
TABLE 33 EUROPE: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 53
TABLE 34 EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 54
TABLE 35 EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 54
TABLE 36 EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 54
TABLE 37 WESTERN EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 55
TABLE 38 WESTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 56
TABLE 39 WESTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 56
TABLE 40 WESTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 56
TABLE 41 GERMANY: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 57
TABLE 42 GERMANY: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 57
TABLE 43 GERMANY: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 57
TABLE 44 UK: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 58
TABLE 45 UK: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 58
TABLE 46 UK: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 58
TABLE 47 FRANCE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 59
TABLE 48 FRANCE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 59
TABLE 49 FRANCE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 59
TABLE 50 ITALY: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 60
TABLE 51 ITALY: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 60
TABLE 52 ITALY: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 60
TABLE 53 SPAIN: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 61
TABLE 54 SPAIN: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 61
TABLE 55 SPAIN: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 61
TABLE 56 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 62
TABLE 57 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 62
TABLE 58 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 62
TABLE 59 EASTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 63
TABLE 60 EASTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 63
TABLE 61 EASTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 63
TABLE 62 ASIA-PACIFIC: PRIMARY MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 64
TABLE 63 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 65
TABLE 64 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 65
TABLE 65 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 65
TABLE 66 JAPAN: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 66
TABLE 67 JAPAN: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 66
TABLE 68 JAPAN: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 66
TABLE 69 CHINA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 67
TABLE 70 CHINA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 67
TABLE 71 CHINA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 67
TABLE 72 INDIA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 68
TABLE 73 INDIA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 68
TABLE 74 INDIA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 68
TABLE 75 AUSTRALIA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 69
TABLE 76 AUSTRALIA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 69
TABLE 77 AUSTRALIA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 69
TABLE 78 SOUTH KOREA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 70
TABLE 79 SOUTH KOREA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 70
TABLE 80 SOUTH KOREA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 70
TABLE 81 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 71
TABLE 82 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 71
TABLE 83 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 71
TABLE 84 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 72
TABLE 85 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 73
TABLE 86 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 73
TABLE 87 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 73
TABLE 88 MIDDLE EAST: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 74
TABLE 89 MIDDLE EAST: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 74
TABLE 90 MIDDLE EAST: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 74
TABLE 91 AFRICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 75
TABLE 92 AFRICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 75
TABLE 93 AFRICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 75
TABLE 94 ALLCELLS: PRODUCTS/SERVICES OFFERED 77
TABLE 95 AMERICAN TYPE CULTURE COLLECTION (ATCC): PRODUCTS/SERVICES OFFERED 79
TABLE 96 AXOL BIOSCIENCE LTD: PRODUCTS/SERVICES OFFERED 81
TABLE 97 CELL BIOLOGICS, INC.: PRODUCTS/SERVICES OFFERED 83
TABLE 98 LONZA: PRODUCTS/SERVICES OFFERED 86
TABLE 99 LONZA: KEY DEVELOPMENTS 86
TABLE 100 MERCK KGAA: PRODUCTS/SERVICES OFFERED 89
TABLE 101 PROMOCELL: PRODUCTS/SERVICES OFFERED 91
TABLE 102 STEMCELL TECHNOLOGIES INC.: PRODUCTS/SERVICES OFFERED 93
TABLE 103 ZENBIO, INC.: PRODUCTS/SERVICES OFFERED 95
TABLE 104 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 98
14 LIST OF FIGURES
FIGURE 1 GLOBAL PRIMARY CELLS MARKET STRUCTURE 16
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 22
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRIMARY CELL MARKET 24
FIGURE 4 DRIVERS IMPACT ANALYSIS 26
FIGURE 5 RESTRAINTS IMPACT ANALYSIS 27
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRIMARY CELL MARKET 29
FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PRIMARY CELL MARKET 31
FIGURE 8 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023 (%) 34
FIGURE 9 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023 & 2030 (USD MILLION) 34
FIGURE 10 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023 (%) 38
FIGURE 11 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023 & 2030 (USD MILLION) 39
FIGURE 12 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023 (%) 42
FIGURE 13 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023 & 2030 (USD MILLION) 42
FIGURE 14 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023(%) 44
FIGURE 15 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023 & 2030 (USD MILLION) 45
FIGURE 16 AMERICAS: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 46
FIGURE 17 NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 48
FIGURE 18 EUROPE: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 53
FIGURE 19 WESTERN EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 55
FIGURE 20 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 64
FIGURE 21 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 72
FIGURE 22 GLOBAL PRIMARY CELLS MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%) 76
FIGURE 23 ALLCELLS: SWOT ANALYSIS 78
FIGURE 24 AMERICAN TYPE CULTURE COLLECTION (ATCC): SWOT ANALYSIS 80
FIGURE 25 AXOL BIOSCIENCE LTD: SWOT ANALYSIS 82
FIGURE 26 CELL BIOLOGICS, INC.: SWOT ANALYSIS 84
FIGURE 27 LONZA: SWOT ANALYSIS 87
FIGURE 28 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 88
FIGURE 29 MERCK KGAA: SWOT ANALYSIS 90
FIGURE 30 PROMOCELL: SWOT ANALYSIS 92
FIGURE 31 STEMCELL TECHNOLOGIES INC.: SWOT ANALYSIS 94
FIGURE 32 ZENBIO, INC.: SWOT ANALYSIS 96
FIGURE 33 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW 97
FIGURE 34 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 99
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
